Exercise as medicine: new trial tests workouts for heart condition
NCT ID NCT05818605
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether 24 weeks of moderate exercise (three 60-minute sessions per week) can improve symptoms and heart function in people with hypertrophic cardiomyopathy, a condition where the heart muscle is thickened. About 70 participants will be randomly assigned to either the exercise program or their usual activity. Researchers will measure changes in exercise capacity, heart strain, and other markers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Moderate Intensity Exercise Program
- What this could lead to
- If it works, this could show that structured exercise safely improves exercise capacity and quality of life for people with hypertrophic cardiomyopathy.
- What could go wrong
- This is a small, early-stage trial with only 70 participants. Exercise may not improve heart function, and some patients might experience discomfort or risks from increased activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients 18 to 80 years of age with diagnosis of hypertrophic cardiomyopathy1 defined by left ventricular hypertrophy with end-diastolic wall thickness 15 mm or greater on 2D echocardiography in the absence of other primary causes of left ventricular hypertrophy or wall thickness between 13 and 15 mm in the presence of other features suggestive of hypertrophic cardiomyopathy, such as systolic anterior motion of the mitral valve leaflets, family history of hypertrophic cardiomyopathy, or positive genetic test result. 2. Left ventricular outflow tract gradient \<30 mmHg at rest and with provocation. 3. Left ventricular ejection fraction ≥ 50% by biplane Simpson's method. 4. Access to exercise equipment at home or at a fitness center. 5. Ability to complete study related testing including online surveys and smart phone use 6. Ability to perform 24 weeks of exercise training Exclusion Criteria: 1. History of exercise-induced syncope or ventricular arrhythmias 2. LVOT obstruction being evaluated for septal reduction therapy; less than 3 months after 3. History of septal reduction therapy - surgery or ablation 4. History of ICD placement in the previous 3 months 5. History of hypotensive response with exercise testing (\>20 mm Hg decrease of systolic blood pressure from baseline blood pressure or an initial increase in systolic blood pressure followed by a decrease of systolic blood pressure \>20 mm Hg) 6. Clinical decompensation in the previous 3 months, defined as New York Heart Association class IV congestive heart failure symptoms or Canadian Cardiovascular Society class IV angina symptoms 7. Left ventricular ejection fraction less than 50% by echocardiography 8. Life expectancy less than 12 months 9. Pregnant or planned pregnancy 10. Inability to exercise owing to any medical or other limitations 11. Unwillingness to refrain from competitive sports, burst activity, or heavy isometric exercise for the duration of the study, if assigned to the non-exercise group.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertrophic cardiomyopathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of California - San Francisco
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a catheter slice thick heart muscle without open surgery?
- A glowing dye could expose hidden heart scarring
- Blood test could offer gentler way to track Children's heart disease
- Heart scans may unlock hidden risks in minority communities
- Global registry aims to unlock clues for heart transplant success in adults born with heart defects
- Heart conditions in kids: study reveals impact on daily life and play